EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Prognostic Value of Glomerular Filtration Rate, Serum Cystatin C, Beta‐2‐Microglobulin and Albuminuria for Death and Chronic Kidney Disease Progression

Isis Cerezo iD, Barbara Cancho iD, Jorge Alberto Rodriguez Sabillon, Alberto Jorge iD, Alvaro Alvarez Lopez iD, Julian Valladares iD, Juan Lopez Gomez iD, Jorge Romero iD, Nicolas Roberto Robles iD

Journal of Clinical Laboratory Analysis · 2025-01 · 39 (2)

DOI: 10.1002/jcla.25139 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 23.12.2024. Verfasst von Isis Cerezo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Nefrologia, Hospital Universitario de Badajoz, Universidad de Extremadura, Badajoz, Spain. Hauptthemen laut MEDLINE: Cystatin C, Glomerular Filtration Rate, beta 2-Microglobulin, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Junta de Extremadura, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Serum creatinine and albuminuria are the core of most CKD prediction and progression risk models. Several biomarkers have been introduced to improve these results such as beta‐2‐microglobulin (B2M) and cystatin C (CysC). Nevertheless, few clinical comparisons of these biomarkers are available. We have compared serum B2M levels with albuminuria, CysC levels, and the CKD‐EPI GFR equations. Designs and Methods A sample of 434 patients were studied: 234 males and 200 females, the mean age was 58.3 ± 15.0 years, and 33.4% have diabetes mellitus. In all patients, plasma B2M, CysC, creatinine, and urinary albumin excretion were analyzed. EGFR was calculated using CKD‐EPI equations for creatinine, CysC, and creatinine‐CysC. The risk of death and CKD progression was evaluated using ROC curves and Cox proportional hazards survivorship models.

Results

For mortality, the highest area under the curve (AUC) was for CysC (0.775, 0.676–0.875). The lowest sensitivity was shown by eGFR (creatinine) (0.298, 0.195–0.401, p < 0.001), eGFR (CysC) (0.216, 0.118–0.314, p < 0.001), and eGFR (creatinine + CysS) (0.218, 0.124–0.312, p < 0.001). For progression to advanced CKD, the highest AUC was for CysC (0.908, 0.862–0.954). The lowest sensitivity was shown by eGFR (creatinine) (0.184, 0.106–0.261, p < 0.001), eGFR (CysC) (0.095, 0.048–0.14, p < 0.001), and eGFR (creatinine+ CysC) (0.087, 0.040–0.134, p < 0.001). CysC, after age, was the second‐best marker of life risk. Contrariwise, for CKD progression, CysC, and albuminuria were the best markers.

Conclusions

The best biomarker of mortality and risk of progression to CKD was CysC. Albuminuria and B2M were the next best options to be used. The lowest sensitivity was shown by estimated eGFR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystatin CGlomerular Filtration Ratebeta 2-MicroglobulinRenal Insufficiency, ChronicAlbuminuriaHumansMaleFemaleMiddle AgedDisease ProgressionPrognosisAgedBiomarkersAdultCreatinineROC Curve

Stichwörter der Autor:innen

albuminuriabeta‐2‐microglobulinchronic kidney diseasecystatin Cglomerular filtration ratemortality

Substanzen

Cystatin Cbeta 2-MicroglobulinBiomarkersCreatinine

Autor:innen und Institutionen

  • Servicio de Nefrologia, Hospital Universitario de Badajoz, Universidad de Extremadura, Badajoz, Spain.
  • Servicio de Bioquímica Clínica, Hospital Universitario de Badajoz, Universidad de Extremadura, Badajoz, Spain.
  • Servicio de Medicina Interna, Hospital Universitario de Badajoz, Universidad de Extremadura, Badajoz, Spain.

ORCID-Profile: Isis Cerezo, Barbara Cancho, Alberto Jorge, Alvaro Alvarez Lopez, Julian Valladares, Juan Lopez Gomez, Jorge Romero, Nicolas Roberto Robles

Förderung

  • Junta de Extremadura
  • Instituto de Salud Carlos III

Zitieren

APA

Cerezo, I., Cancho, B., Rodriguez Sabillon, J. A., Jorge, A., Alvarez Lopez, A., Valladares, J., Lopez Gomez, J., Romero, J., & Robles, N. R. (2025). Comparative Prognostic Value of Glomerular Filtration Rate, Serum Cystatin C, Beta‐2‐Microglobulin and Albuminuria for Death and Chronic Kidney Disease Progression. Journal of Clinical Laboratory Analysis, 39(2). https://doi.org/10.1002/jcla.25139

Vancouver

Cerezo I, Cancho B, Rodriguez Sabillon JA, Jorge A, Alvarez Lopez A, Valladares J, et al. Comparative Prognostic Value of Glomerular Filtration Rate, Serum Cystatin C, Beta‐2‐Microglobulin and Albuminuria for Death and Chronic Kidney Disease Progression. Journal of Clinical Laboratory Analysis. 2025;39(2). doi:10.1002/jcla.25139

BibTeX
@article{Cerezo2025,
  author = {Cerezo, Isis and Cancho, Barbara and Rodriguez Sabillon, Jorge Alberto and Jorge, Alberto and Alvarez Lopez, Alvaro and Valladares, Julian and Lopez Gomez, Juan and Romero, Jorge and Robles, Nicolas Roberto},
  title = {Comparative Prognostic Value of Glomerular Filtration Rate, Serum Cystatin C, Beta‐2‐Microglobulin and Albuminuria for Death and Chronic Kidney Disease Progression},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2025},
  volume = {39},
  number = {2},
  doi = {10.1002/jcla.25139}
}
Kostenlos starten →